Intellia Therapeutics, Inc.·4

Apr 18, 5:04 PM ET

CHASE WILLIAM J 4

4 · Intellia Therapeutics, Inc. · Filed Apr 18, 2023

Insider Transaction Report

Form 4
Period: 2023-04-14
Transactions
  • Award

    Common Stock

    2023-04-14+10,48317,283 total
  • Award

    Stock Option (Right to Buy)

    2023-04-14+14,93114,931 total
    Exercise: $38.16Exp: 2033-04-13Common Stock (14,931 underlying)
Footnotes (2)
  • [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
  • [F2]This option was granted on April 14, 2023 with respect to 14,931 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on April 14, 2024 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION